key: cord-0948490-by5ulqgp
authors: Rozenbaum, Daniel; Shreve, Jacob; Radakovich, Nathan; Douggal, Abhijit; Jehi, Lara; Nazha, Aziz
title: Personalized Prediction of Hospital Mortality in COVID-19 positive patients
date: 2021-05-12
journal: Mayo Clin Proc Innov Qual Outcomes
DOI: 10.1016/j.mayocpiqo.2021.05.001
sha: 0f03422f9b2a38f30c6a7e887bc91f978cae1087
doc_id: 948490
cord_uid: by5ulqgp

Objective To develop predictive models for in-hospital mortality and length of stay (LOS) for COVID-19 positive patients. Patients and Methods We performed a multicenter retrospective cohort study of hospitalized COVID-19 positive patients. A total of 764 patients admitted to 14 different hospitals within the Cleveland Clinic from 03/09/2020 to 05/20/2020 who had reverse transcriptase-polymerase chain reaction proven coronavirus infection were included. We used LightGBM, a machine learning algorithm, to predict in-hospital mortality at different time points (after 7 days, 14 days, and 30 days of hospitalization) and in-hospital LOS. Results Among 764 patients, 116 (15%) either died (n = 87) or were transitioned to hospice care (n = 29) during their hospitalization. The median LOS was 5 days (range 1 - 44 days) for patients admitted to the regular nursing floor and 10 days (range 1-38 days) for patients admitted to the intensive care unit (ICU). Patients who died during hospitalization were older, initially admitted to the ICU, more likely to be white and to have worse organ dysfunction compared to patients who survived their hospitalization. Using the 10 most important variables only, the final model’s area under the Receiver Operating Characteristics curve was 0.86 for 7-day, 0.88 for 14-day, and 0.85 for 30-day mortality in the validation cohort. Conclusions We developed a decision tool that can provide explainable and patient-specific prediction of in-hospital mortality and LOS for COVID-19 positive patients. The model can aid healthcare systems in bed allocation and distribution of vital resources.

Despite several international and local efforts, the coronavirus pandemic caused by the acute respiratory virus (SARS-CoV-2) has infected more than 122 million individuals worldwide, and more than 2.7 million people have died to date. 1 The pandemic is far from over with rising new cases in several parts of the United States and the world. Consequently, healthcare systems continue to face several challenges regarding bed availabilities/allocations and resource utilization.

While some infected patients can be asymptomatic, others can suffer from severe respiratory distress syndrome, multiorgan failure, and death. Thus, identifying patients with higher risk of early mortality during their hospitalization could aid hospitals and healthcare providers in predicting the disease trajectory, distributing vital resources efficiently, and consequently, improving patients' outcomes.

Here, we developed a clinical-decision tool that uses clinical and demographic variables within twenty-four hours of hospitalization to provide personalized predictions of patient mortality and length of stay (LOS) that are specific for a given patient.

All patients admitted to our healthcare system from 03/09/2020 to 05/20/2020 who had reverse transcriptase-polymerase chain reaction proven COVID19 infection were included in our database (n = 962). We excluded patients: 1) that had not been discharged or died by 05/21/2020 J o u r n a l P r e -p r o o f (n = 103); 2) for whom discharge disposition was unknown (due to missing information or transfer to another hospital; n = 89); and 3) who were younger than 18 years (n = 6). The study was approved by the Cleveland Clinic Institutional Review Board and conducted in accordance with the declaration of Helsinki.

For each patient, demographic, clinical, and laboratory variables (109 variables, Supplementary Table 1 ) were included and structured from the electronic healthcare record. All variables were collected within the first 24 hours of hospitalization. Twenty two percent of our data was missing, mostly because some laboratory tests were not ordered on the day of admission or the test was not ordered at all for the patient. Missing data was handled by the built-in algorithm from the machine learning model used in our analysis.

The main outcomes evaluated were mortality at 7, 14, and 30 days of hospitalization and length of hospital stay, which was defined as the time between hospitalization and death or discharge from the hospital. We also built a model for prediction of ICU transfer (or death before ICU transfer) among patients admitted to the regular nursing floor.

To assure that all variables are treated equally regardless of their significance in univariate analysis and to account for the variables that can be significant only in the context of other variables, we used a machine learning model, LightGBM, 2 in our analysis. LightGBM is a model based on the gradient boosting framework. In gradient boosting, models with weak predictive capability, such as decision trees, are used together to achieve high predictive J o u r n a l P r e -p r o o f performance. During training of a gradient boosting model, decision trees are created using the available variables to separate instances belonging to different classes (e.g., survivors versus non-survivors). These decision trees are created in a sequential fashion to minimize the prediction errors made by the previous trees. Once facing a new case, the model will use the framework of decision trees created during training to classify the new example.

The dataset was divided randomly into training (80%) and test (20%) sets and the models were initially trained with all our variables. The most influential ten variables as determined by the values originated by the SHapley Additive exPlanations (SHAP) algorithm 3 (algorithm that is widely used to determine the most important variables that impacted a model's decision) were extracted. These were ranked from the most to the least important variable, and used to fit reduced, clinically usable, versions of our models.

Hyperparameter optimization using a Bayesian optimization algorithm was obtained to assure the most robust models were used and 10-fold cross-validation was also used to assure the reproducibility of the final models. Model performance in the validation set is reported using the area under the receiver operating characteristics curve (ROC AUC).

A total of 764 patients were included in the analysis; 116 (15%) either died (n = 87) or were transitioned to hospice care (n = 29). The median age was 64 years (range: 19-98 years) and 147 patients (19%) were admitted directly to the intensive care unit (ICU). The median LOS was 5 days (range 1 -44 days) for patients admitted to the regular nursing floor and 10 days (range 1-J o u r n a l P r e -p r o o f 38 days) for patients admitted to the ICU. Table 1 summarizes the clinical characteristics of our cohort. As expected, patients who died during their hospitalization were older, more likely to be initially admitted to the ICU, and had worse organ dysfunction and inflammatory biomarkers compared to patients who survived their hospitalization, Table 1 . Interestingly, males did not have worse outcomes compared to females and African American patients had lower mortality rate compared to whites in our cohort, Table 1 .

A total of 109 clinical variables (Supplementary Table 1 We also used the same methodology to build a model to predict ICU transfer (or death prior to ICU transfer) among patients admitted initially to the regular nursing floor. The final model ROC AUC with only the top 10 variables was 0.80. The top 10 clinical variables that impacted risk of ICU transfer as well as 30-day mortality in patients older than 70 years old can also be found in Figure 1 .

In this study, we developed personalized prediction models that use clinical variables within 24hours of admission to predict mortality and LOS that are specific for COVID-19 patients. The proposed models showed robust AUC in predicting mortality and LOS at different time points during hospitalization. Our models' predictions could alert physicians regarding adverse outcomes for hospitalized patients with COVID such as hospital mortality and transfer to ICU. It can also help hospitals manage a COVID surge by identifying the expected length of stay in the hospital and ICU. We also explored the clinical variables that impacted these outcomes during hospitalization and showed that while some variables like age, lactate dehydrogenase, and ferritin have a significant impact on mortality at each time point, others like procalcitonin can only affect mortality after 14 and 30 days. More importantly, our models can provide an explainable prediction that is specific for a given patient. This explainability will allow physicians to understand the significant clinical variables that impacted their patients' outcomes.

Several studies have evaluated the impact of clinical variables on mortality during hospitalization for COVID-19 patients. [4] [5] [6] [7] Although all showed that age and comorbidities could impact the J o u r n a l P r e -p r o o f outcome, the impact of other clinical variables varies. These differences in the outcomes could be related to the difference in the methodology of conducting the multivariate analyses. Our machine learning model included all the clinical variables initially to assure that all variables are treated equally regardless of their significance in univariate analyses. We then focused on the analysis of the top 10 variables that impacted the overall outcomes. Although machine learning models are often viewed as a "black-box," our model can provide an explainable output that is specific for a given patient.

Our study has important limitations. First, as a retrospective study importing data from the EMR, a high proportion of missing data is expected. While missing data will worsen the performance of a prediction algorithm, empirically we were able to verify that the model still had robust performance on our test set (i.e., validation cohort). Second, given that each surge may have its own specific characteristics and that all patients came from hospitals within the same healthcare system, our ability to generalize our findings may be limited to some extent.

In conclusion, we built personalized prediction models to predict outcomes for hospitalized COVID19 patients. The models can aid physicians and healthcare systems in understating the disease trajectory and expected outcomes for a given patient.

We wish to acknowledge the COVID-19 Enterprise Research Registry Workstream for their assistance with data collection. 

World Health Organization. Weekly Epidemiological Update -23

LightGBM: A Highly Efficient Gradient Boosting Decision Tree

A Unified Approach to Interpreting Model Predictions. Paper presented at: Advances in Neural Information Processing Systems

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

OpenSAFELY: factors associated with COVID-19 death in 17 million patients

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China

Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China